MRSA is affecting more than 2 million Americans each year during hospital stays. We may have the Cure. More Details about MRSA, Staph Infection, Nasal Infection here.

Learn how your ad can appear here! Get Your Vision Board Iphone/Ipod App and start moving toward your dreams today! Feature Articles Compassionate Business in Action... Fast Track Your Journey to Home Business Succ... Simplify Your Holidays,Stuffing is for TURKEY... Money Can Be Made on the Web... How To Use The Socratic Method To Create And ... How Does A Business Goddess Make Decisions?... Rebrand Your Company to Boost Your Bottom Lin... Cinnamon Rolls, Breast Cancer and Your Busine... Click here for more >>

VENICE, FL-- On the heels of the recent announcement stating a commitment to develop a product to attack MRSA -- the so-called "super bug," SinoFresh HealthCare, Inc. (OTC BB:SFSH.OB - News) announced today the continuation of a series of development activities to implement that commitment. This is a study, which will be in the lab phase by the end of July 2008, and according to Dr. John Todhunter, an outside consultant to SinoFresh, "is expected to give robust proof of concept for the nasal formulation designed to kill MRSA hiding in the nose."

The SinoFresh formulation evolves from a well-established antimicrobial agent which is classed by FDA as "generally recognized as safe and effective" and has been used in other applications for a number of years. The present study follows an in vitro study conducted at Public Health Research Institute under the direction of Dr. Barry Kreiswirth who heads the institute's Tuberculosis Center and Hospital Infections Program, and will be an in vivo study using a well validated model reflecting demonstrated results relative to MRSA colonizing in the human nose. "Efficacy has been proven in a 'test tube' and now we're moving to show MRSA killing properties in a living nose," said Dr. Todhunter, President of SRS International.

MRSA (which stands for methicillin resistant Staphylococcus aureus) is a growing concern in the health care community. It hides in the nasal passages and then gets on the skin where it can cause severe, virulent infections which can lead to disfigurement and sometimes death. It is also highly antibiotic resistant which makes MRSA infections difficult to treat.

According to Dr. Todhunter there is an apparent consensus in the health care community that having a high nasal load of MRSA is associated with increased rates of MRSA infection. Eradication of nasal MRSA colonies is seen as a potentially important weapon in reducing the spread of MRSA. The antibiotic Mupirocin is currently the treatment of choice for reducing nasal MRSA loads. It has become less effective as MRSA resistance to it has emerged. SinoFresh's approach to killing MRSA in the nasal passages is based on the potent ability of the SinoFresh active ingredient as an antimicrobial which destroys bacterial cell walls and membranes. This happens by physical means rather than by an effect on bacterial metabolism which is how antibiotics work. "Since bacteria can in effect change their metabolism to be resistant to antibiotics, but can't very well change the laws of physics, the chances for development of resistance to SinoFresh's nasal formulation is much lower," said Dr. Todhunter.

According to William Wilferth, VP for Research and Development at SinoFresh, "We stated earlier we were going to be very aggressive in the pursuit of MRSA solutions. Our commitment in launching this most recent in vivo study moves us further down that path." Charles Fust, CEO of SinoFresh HealthCare, Inc., stated, "I remain cautiously optimistic in light of published statements on the topic of MRSA, exampled by, the average incremental cost per patient with an acquired infection is $15,275 multiplied by at least 2,000,000 infections indicating possible cost to hospitals of $30.5B, [Clinical Infectious Diseases (v. 36, 2003) 1424-1432], suggests a potentially rewarding market receptive to new alternatives.". For more information, visit www.sinofreshstore.com

Mr. Fust is a chemical engineer, whose research has resulted in approximately 130 domestic and international patents, including the patents underlying the SinoFresh products. Mr. Fust began the development of the Company’s products in 1989. His expertise in the health care community has provided him with the opportunity to chair various health care boards, mainly Otorhinolaryngology related. Mr. Fust’s business background covers ownership and management in international companies. Mr. Fust has been the Chief Executive Officer and Chairman of SinoFresh Lab LLC from 1999 to the present and the Chief Executive Officer and Chairman of SinoFresh HealthCare, Inc. from 2002 to the present. He holds a bachelor degree in Chemical Engineering from Auburn University and has a professional affiliation with the American Association of Pharmaceutical Scientists. http://www.sinofreshstore.com

Click to buy Sinofresh products here www.sinofreshstore.com

Contact:
William Wilferth, R. Ph, M.S.
billwilferth@sinofresh.com

More Details about MRSA, Staph Infection, Nasal Infection here.

Translate to Spanish Translate to French Translate to German Translate to Italian Translate to Portuguese

This press release has been viewed 858 time(s).

Videos You Might Enjoy on This Subject

• Domestic Violence Healthcare Response
  Healthcare providers are in the best position to assess for domestic violence, yet have obstacles to doing so. See the benefits to moving beyond these obstacles for those you serve. And discover an accurate, convenient and confidential way to assess for domestic abuse. ... More info here.

Related Articles

• Order Tramadols with free prescription service from OrderTramadols.net
• How to Cure Erectil Dysfunction
• Billing & collections: Avoid on-call fraud accusations
• Billing & collections: Avoid on-call fraud accusations
• Surprising Health Benefit
• 3 Vital Principles You Must Know To Burn Fat Faster
• Creating the Perfect Hot Tub Spa Experience
• Electric Cigarette Try It For Free
• Say good bye to toothache forever review|Buy Say good bye to toothache forever review.
• Cardiology coding: Keep pace with 2010 CPT Category III codes
• Cardiology coding: Keep pace with 2010 CPT Category III codes
• PR: Eagle Eye Vision Helps You Soar to Greater Heights with the Newest Eye-Care
• Importance of Youth Drug Testing at High Schools
• What You Need to Know about Hypersomnia
• Hair Transplant Surgery can Improve your Love Life
• Hair Loss Treatment
• Do away with the IT-Clinician Gap: Here's how
• Estrogen Usage May Not be Harmful for Some Women
• Is Gene Testing for Breast Cancer Reliable?
• Honey | Why you should never buy this product from the High Street
• Take Control: Help Keep Your Family Healthy this Season
• Home Siding Options Get A New Look For Your Home
• What Is The Price Of Health Insurance?
• What Is The Price Of Health Insurance?
• Deal With H1N1 Wisely